Skip to main content

Headlines

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Neumora Therapeutics Enters Oversold Territory (NMRA)
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Candel Therapeutics' CAN-2409 Enhances NSCLC Survival In Phase 2 Trial; Stock Surges
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Up 165% This Year Will Dyne Therapeutics Continue Its Stellar Run?
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
First Week of July 19th Options Trading For Beam Therapeutics
posted:
by: Nasdaq Options
#channels:: #All, #Business, #Stocks, #Nasdaq, #Options, #StockOptions, #NasdaqOptions
Is It Too Late to Buy Viking Therapeutics Stock?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Dyne Therapeutics Prices Public Offering Of 10.50 Mln Shares At $31.00/shr
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Oppenheimer Initiates Coverage of Capricor Therapeutics (CAPR) with Outperform Recommendation
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Virios Therapeutics Plans To Sell Up To $2.1 Mln In Shares Of Its Common Stock In Public Offering
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
The Analyst Verdict: CARISMA Therapeutics In The Eyes Of 4 Experts
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk
Raymond James Upgrades Viking Therapeutics (VKTX)
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Plus Therapeutics Inc. Q1 Loss Decreases, Beats Estimates
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk
Expert Ratings For Capricor Therapeutics
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk
Evaluating Amicus Therapeutics: Insights From 6 Financial Analysts
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk